H.R.1732 - Synthetic Drug Control Act of 2017115th Congress (2017-2018) |
|Sponsor:||Rep. Dent, Charles W. [R-PA-15] (Introduced 03/27/2017)|
|Committees:||House - Energy and Commerce; Judiciary|
|Latest Action:||House - 04/12/2017 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.1732 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (03/27/2017)
Synthetic Drug Control Act of 2017
This bill directs the Drug Enforcement Administration to update schedule I of the Controlled Substances Act to include certain synthetic substances. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
The bill exempts from treatment as a controlled substance any such synthetic substance that is manufactured, distributed, and used exclusively for research.